News

Campath is approved to treat B-cell chronic lymphocytic leukemia. The company had to halt its study using the drug for treating MS in September 2005, after three patients

Peter Hersey, an oncologist and authority on melanoma, said that treatment of one of the tumors with PV-10 led to complete eradication of all four tumors that had

The US supply chain is part of Roche’s global production network, which will be capable of producing 400 million treatment courses of Tamiflu annually by the end of

Swiss biotechnology company Mondobiotech will receive a $7.5 million upfront payment and up to $30 million in milestones payments for successful development and commercialization of Aviptadil in PAH

The previously announced phase II randomized study will compare AZD6244 to temozolomide in the treatment of stage III / IV melanoma patients. AstraZeneca expects to enroll up to

During the one-year study, patients using Exenatide showed improvements in three important measures of blood glucose control: fasting blood glucose, postprandial blood glucose, and hemoglobin A1C (HbA1C). Exenatide

Januvia is an investigational once-daily medicine that, if approved, would potentially be the first in a new class of oral drugs in the US that enhance the body's

Galvus showed a 1.8% reduction in blood sugar levels, comparable to Avandia, but without weight gain overall and with a lower incidence of edema (fluid retention) – both

While passive smoke exposure could result in decreased absorption, Exubera could be used by patients who were exposed to a smoky environment, the company said. The treatment can